Explore more Johnson & Johnson sites:
Share
Back to top
Mental health
-
From cultural stigma to language barriers, getting necessary treatment can be challenging for these groups. For Hispanic Heritage Month, learn more about what the company is doing to help people surmount unique obstacles to get the resources they need.
-
Two new Johnson & Johnson initiatives aim to remove the obstacles people of color and the LGBTQIA+ community have historically faced in getting help with mental illness. The head of Janssen Neuroscience, Courtney Billington, explains why breaking these barriers is a priority—and a personal mission.
-
Injections that allow people with schizophrenia to go longer between treatments. Digital tools that may lead to the creation of more effective medications. Programs that ensure mental illness is properly diagnosed. These are just a few of the ways Johnson & Johnson is addressing the largest unmet need in healthcare.
-
As the pandemic spread, many young people experienced anger, stress—even depression. But a Save the Children initiative supported by Johnson & Johnson is teaching them how to manage their difficult emotions.
-
For National Disability Independence Day, we're celebrating how the company has committed to being a safe space for people with diverse physical, neurological and mental health abilities—and sees them as crucial business assets.
-
Meet four students dedicated to removing the stigma of mental illness and increasing access to crucial treatments around the world—with the help of the Global Mental Health Scholarship Fund.
-
Two experts in the field share the latest understanding and research into conditions like pediatric plaque psoriasis, juvenile idiopathic arthritis and pediatric active psoriatic arthritis—diseases that afflict children and can have long-term damaging effects into adulthood if not properly treated.
-
Vusumuzi Christopher Mnqayi didn't realize how much of a toll his job as a community health worker in South Africa was taking on his mental health. That is, until he received coaching that has transformed the way he copes with the challenges of his crucial front line role.
-
On the latest episode of The Road to a Vaccine, host Lisa Ling delves into the effects of the pandemic on kids. We sat down with one of the guests, Vikram Patel, a professor at Harvard Medical School, to find out the most pressing questions on his mind.
-
At the height of the outbreak in New York City, Dr. Ed Kuffner took a leave of absence from his job to volunteer at a Brooklyn hospital hard hit by the pandemic. He shares what the experience taught him about his own strengths—and ideas for coping during this unprecedented time.
-
Cancer. Alzheimer’s. Even suicide risk. The clues to preventing these and other conditions could be found in our DNA—and these scientists are at the forefront of promising new genetic data research to uncover them.
-
From a $10 million pledge to UNICEF in support of health workers to promising news about a preventive HIV vaccine regimen, the company’s new 2018 Health for Humanity Report details how Johnson & Johnson is dedicated to creating a better future for everyone, everywhere.
-
A staggering 1 in 7 women suffer from perinatal mood disorders, which can begin as early as pregnancy. We take a look at how these scientists are working to find ways to help halt depression in moms at the most critical juncture: before it starts.
-
From scientists in research labs to CEOs at companies across the country, here's how one healthcare company is partnering with people from all walks of life to help drive change in how we treat mental disorders—and the stigma often associated with them.
-
Imade Nibokun Borha, 31, shares the raw truth about living with treatment-resistant depression—and the surprising silver lining she's found through her diagnosis.
